Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS
Clinical trial NCT03496766 · TERMINATED
Trial details
- NCT number
- NCT03496766
- Sponsor
- Spanish Lung Cancer Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-07
- Primary completion
- 2022-10-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.